Search

Search Constraints

You searched for: Author/Creator Genge, Angela

Search Results

21. Oral edaravone demonstrated a favorable safety profile in patients with amyotrophic lateral sclerosis after 48 weeks of treatment. Issue 2 (28th December 2022)

22. Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial. Issue 8 (August 2018)

23. Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial. Issue 8 (August 2018)

24. Pompe Disease: Diagnosis and Management. Evidence-Based Guidelines from a Canadian Expert Panel. (8th April 2016)

25. Preface: promoting research in PLS: current knowledge and future challenges. (2nd November 2020)

26. Prescription and acceptance of durable medical equipment in FORTITUDE-ALS, a study of reldesemtiv in ALS: post hoc analyses of a randomized, double-blind, placebo-controlled clinical trial. Issue 3 (3rd April 2022)

27. Provincial Differences in the Diagnosis and Care of Amyotrophic Lateral Sclerosis. (15th November 2018)

28. Radicava/Edaravone Findings in Biomarkers From Amyotrophic Lateral Sclerosis (REFINE-ALS): Protocol and Study Design. Issue 4 (August 2021)

29. Randomized phase 2 study of ACE‐083, a muscle‐promoting agent, in facioscapulohumeral muscular dystrophy. Issue 1 (9th May 2022)